Sciensus Rare

Major Drugs - N/A, N/A, us

Sciensus Rare Employees
Julie Wilkinson

Rare Services Project and Implementation Manager

Contact Julie Wilkinson

Rob Clements

Vice President Of Business Development

Contact Rob Clements

Paolo Pappalardo

General Manager Southern EU

Contact Paolo Pappalardo

Yalcin Trana

Vice President Emerging Markets

Contact Yalcin Trana

Andre Muller

General Manager Northern Europe

Contact Andre Muller

Stephen Tice

Head of Commercial Assessment

Contact Stephen Tice

Sharron Pearce

Account Director, Client Delivery

Contact Sharron Pearce

View All Sciensus Rare Employees Contact All Sciensus Rare Employees
Sciensus Rare Details

Sciensus Rare launches with two main aims: to ensure that patients and their families have access to the rare disease medicines and care they need, and to help biotech and pharmaceutical companies safely launch and efficiently deliver vital medication, no matter where a patient lives or the regulatory governance of that country. The business will continue to help emerging, mid-sized, and major biotech and pharmaceutical companies gain market access in Europe and beyond, expanding Healthcare at Home's existing rare disease and orphan medicines services further geographically and by therapy area, across five main services: - Clinical trials in the home- Medicines access- Bespoke supply chain management- Patient and family support- Outcome monitoring in the homeAccording to Eurostat, the market for rare disease pharmaceutical medicines services is expected to more than double in size over the next few years, growing from €1.6bn in 2018 to €3.3bn in 2025, as the number of products requiring more complex services to support them grows. Sciensus Rare aims to meet the growing demand by creating a unique, science-led approach to help pharmaceutical partners reduce time to market for innovative, high cost, new medicines in a rapidly changing marketplace, helping to eliminate unnecessary costs and inefficiencies in the drug development process. Sciensus Rare's services build on Healthcare at Home's three decades of experience in treating rare disease patients. In that time, the business has treated more than 52,000 patients at home, and collaborated with over 20 rare disease pharmaceutical companies and over 4,000 healthcare providers in mainland Europe. BioMarin, which specialises in developing and commercialising biopharmaceuticals for rare diseases driven by genetic causes, has been working with Healthcare at Home since 2006 and now sees a quarter of its global sales delivered through this model. http://www.sciensusrare.com

Sciensus Rare logo, Sciensus Rare contact details
Website: sciensusrare.com
Employees: 1000 - 4999
HQ: N/A
Location: N/A, N/A, us
Revenue: 2.5 - 5 Million
Pharmaceuticals
Sciensus Rare Technologies
Email Providers

Mimecast

Hosting

Amazon AWS

Other

Mobile Friendly

Online Video Platforms

Vimeo

View All Technologies Used At Sciensus Rare

Contacting Sciensus Rare: Connect with Executives and Employees

Get in Touch with Sciensus Rare Executives and Employees

Connecting with Sciensus Rare's Executives and Workforce

Accessing Contact Information for Sciensus Rare Executives

Connecting with Sciensus Rare: Reach Out to Their Team

Discover How to Contact Sciensus Rare Executives and Staff

Looking to connect with Sciensus Rare executives or employees?

Seeking to Get in Touch with Sciensus Rare Executives or Staff?

Want to Reach Out to Sciensus Rare Executives or Team Members?

In Search of Contact Details for Sciensus Rare Professionals?

Connecting with Sciensus Rare: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z